An overview of pancreatic neuroendocrine tumours.
This article outlines pancreatic neuroendocrine tumours including aetiology, investigations needed to make a diagnosis and the treatment options. It aims to provide general and oncology nurses with information about these rare but challenging tumours and it also offers some suggestions on how to improve patient care.
Burgess
A
A
Christie Hospital NHS Foundation Trust, Manchester. andrea.burgess@christie.nhs.uk
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001706:Biopsy; D003131:Combined Modality Therapy; D055088:Early Detection of Cancer; D006801:Humans; D015994:Incidence; D009367:Neoplasm Staging; D018358:Neuroendocrine Tumors / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D009859:Oncology Nursing; D010166:Palliative Care; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D017410:Practice Guidelines as Topic; D035583:Rare Diseases; D012017:Referral and Consultation; D012307:Risk Factors; D013004:Somatostatin / Q000031:analogs & derivatives; D006113:United Kingdom / Q000453:epidemiology
D000970:Antineoplastic Agents; D013004:Somatostatin